SEC Filings | Carisma Therapeutics Inc.

Filing date	Description	Form	View
May 02, 2023	EFFECT	EFFECT	View HTML 9999999995-23-001237.pdf 9999999995-23-001237.rtf 9999999995-23-001237.xls
Apr 28, 2023	Official notification to shareholders of matters to be brought to a vote ("Proxy")	DEF 14A	View HTML 0001104659-23-052069.pdf 0001104659-23-052069.rtf 0001104659-23-052069.xls
Apr 28, 2023	An annual report to security holders	ARS	View HTML 0001104659-23-052074.pdf 0001104659-23-052074.rtf
Apr 28, 2023	CORRESP	CORRESP	View HTML 0001104659-23-052082.pdf 0001104659-23-052082.rtf 0001104659-23-052082.xls
Apr 28, 2023	CORRESP	CORRESP	View HTML 0001104659-23-052078.pdf 0001104659-23-052078.rtf 0001104659-23-052078.xls
Apr 20, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-003958.pdf 0000000000-23-003958.rtf
Apr 20, 2023	UPLOAD	UPLOAD	View HTML 0000000000-23-003964.pdf 0000000000-23-003964.rtf
Apr 17, 2023	Simplified registration form	S-3	View HTML 0001104659-23-046286.pdf 0001104659-23-046286.rtf 0001104659-23-046286.xls
Apr 17, 2023	Simplified registration form	S-3	View HTML 0001104659-23-046294.pdf 0001104659-23-046294.rtf 0001104659-23-046294.xls
Apr 17, 2023	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	View HTML 0001104659-23-046300.pdf 0001104659-23-046300.rtf 0001104659-23-046300.xls

Data provided by Kaleidoscope.